Pten loss in the bone marrow leads to G-CSF-mediated HSC mobilization

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• PTEN (phosphatase and tensin homolog) is a tumor suppressor that inhibits the PI3K pathway, regulating cell growth, proliferation, survival, and migration.
• Conditional deletion of Pten in mice causes splenomegaly and leukemia, linked to hematopoietic stem cell (HSC) relocation from bone marrow to spleen.

Purpose of the Study:

• To investigate the role of PTEN in HSC regulation and leukemia initiation.
• To elucidate the mechanism by which Pten deletion leads to HSC mobilization and leukemia.

Main Methods:

• Conditional Pten deletion in mice using MxCre or Scl-CreER(T) models.
• Analysis of HSC behavior, cell cycle status, and self-renewal activity in the bone marrow and spleen.
• Assessment of PI3K pathway activation in myeloid cells and HSCs.
• Investigation of G-CSF levels and the effect of G-CSF deficiency on Pten-deficient mice.

Main Results:

• Pten loss did not exhaust dormant HSCs; they retained self-renewal capacity.
• Pten deficiency upregulated the PI3K pathway in myeloid cells, not HSCs.
• Myeloid cells in Pten-deficient mice secreted high levels of G-CSF, mobilizing HSCs to the spleen.
• Deletion of Pten in G-CSF-deficient mice rescued splenomegaly, myeloproliferative disease, and HSC accumulation.

Conclusions:

• PTEN is crucial for preventing excessive G-CSF production by myeloid and stromal cells.
• PTEN's primary role in this context is not within HSCs but in regulating G-CSF secretion.
• PTEN deficiency drives leukemia initiation indirectly by causing HSC relocation to the spleen via G-CSF.